Hot off the heels of the Wyeth (WYE) and Pfizer (PFE), as well as the Merck (MRK) and Schering-Plough (SGP) deals, we thought it would be fitting to post up this graphic hypothesizing possible mergers in the drug industry. (Keep in mind that this was released before the MRK bid). Courtesy of the NYT, we see a great graphic depicting the current landscape where it hypothesizes that Crucell, Bristol Myers Squibb, and Gilead would have the most plausible suitors.
(click to enlarge)
